BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pawar A, Singh S, Rajalakshmi S, Shaikh K, Bothiraja C. Development of fisetin-loaded folate functionalized pluronic micelles for breast cancer targeting. Artif Cells Nanomed Biotechnol 2018;46:347-61. [PMID: 29334247 DOI: 10.1080/21691401.2018.1423991] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 7.4] [Reference Citation Analysis]
Number Citing Articles
1 Sarvarian P, Samadi P, Gholipour E, khodadadi M, Pourakbari R, Akbarzadelale P, Shamsasenjan K. Fisetin-loaded grape-derived nanoparticles improve anticancer efficacy in MOLT-4 cells. Biochemical and Biophysical Research Communications 2023. [DOI: 10.1016/j.bbrc.2023.03.040] [Reference Citation Analysis]
2 Verma P, Gupta GD, Markandeywar TS, Singh D. A Critical Sojourn of Polymeric Micelles: Technological Concepts, Recent Advances, and Future Prospects. Assay Drug Dev Technol 2023;21:31-47. [PMID: 36856457 DOI: 10.1089/adt.2022.079] [Reference Citation Analysis]
3 Kumar RM, Kumar H, Bhatt T, Jain R, Panchal K, Chaurasiya A, Jain V. Fisetin in Cancer: Attributes, Developmental Aspects, and Nanotherapeutics. Pharmaceuticals 2023;16:196. [DOI: 10.3390/ph16020196] [Reference Citation Analysis]
4 Martín Giménez VM, Moretton MA, Chiappetta DA, Salgueiro MJ, Fornés MW, Manucha W. Polymeric Nanomicelles Loaded with Anandamide and Their Renal Effects as a Therapeutic Alternative for Hypertension Treatment by Passive Targeting. Pharmaceutics 2023;15. [PMID: 36678805 DOI: 10.3390/pharmaceutics15010176] [Reference Citation Analysis]
5 Kong X, Qi Y, Wang X, Jiang R, Wang J, Fang Y, Gao J, Chu Hwang K. Nanoparticle Drug Delivery Systems and Their Applications as Targeted Therapies for Triple Negative Breast Cancer. Progress in Materials Science 2023. [DOI: 10.1016/j.pmatsci.2023.101070] [Reference Citation Analysis]
6 de Castro KC, Coco JC, Dos Santos ÉM, Ataide JA, Martinez RM, do Nascimento MHM, Prata J, da Fonte PRML, Severino P, Mazzola PG, Baby AR, Souto EB, de Araujo DR, Lopes AM. Pluronic® triblock copolymer-based nanoformulations for cancer therapy: A 10-year overview. J Control Release 2023;353:802-22. [PMID: 36521691 DOI: 10.1016/j.jconrel.2022.12.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 de Morais FAP, De Oliveira ACV, Balbinot RB, Lazarin-Bidóia D, Ueda-Nakamura T, de Oliveira Silva S, da Silva Souza Campanholi K, da Silva Junior RC, Gonçalves RS, Caetano W, Nakamura CV. Multifunctional Nanoparticles as High-Efficient Targeted Hypericin System for Theranostic Melanoma. Polymers (Basel) 2022;15. [PMID: 36616529 DOI: 10.3390/polym15010179] [Reference Citation Analysis]
8 Talaat SM, Elnaggar YSR, El-Ganainy SO, Gowayed MA, Abdel-Bary A, Abdallah OY. Novel bio-inspired lipid nanoparticles for improving the anti-tumoral efficacy of fisetin against breast cancer. Int J Pharm 2022;628:122184. [PMID: 36252641 DOI: 10.1016/j.ijpharm.2022.122184] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Chaudhuri A, Ramesh K, Kumar DN, Dehari D, Singh S, Kumar D, Agrawal AK. Polymeric micelles: A novel drug delivery system for the treatment of breast cancer. Journal of Drug Delivery Science and Technology 2022;77:103886. [DOI: 10.1016/j.jddst.2022.103886] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Cunha C, Daniel-da-silva AL, Oliveira H. Drug Delivery Systems and Flavonoids: Current Knowledge in Melanoma Treatment and Future Perspectives. Micromachines 2022;13:1838. [DOI: 10.3390/mi13111838] [Reference Citation Analysis]
11 Girase ML, Sugandhi VV, Ige PP, Jain PD, Nangare SN. Design of surface tailored carboxymethyl dextran-protein based nanoconjugates for paclitaxel: Spectroscopical characterizations and cytotoxicity assay. International Journal of Biological Macromolecules 2022. [DOI: 10.1016/j.ijbiomac.2022.09.271] [Reference Citation Analysis]
12 Ayana G, Ryu J, Choe SW. Ultrasound-Responsive Nanocarriers for Breast Cancer Chemotherapy. Micromachines (Basel) 2022;13:1508. [PMID: 36144131 DOI: 10.3390/mi13091508] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Junnuthula V, Kolimi P, Nyavanandi D, Sampathi S, Vora LK, Dyawanapelly S. Polymeric Micelles for Breast Cancer Therapy: Recent Updates, Clinical Translation and Regulatory Considerations. Pharmaceutics 2022;14:1860. [PMID: 36145608 DOI: 10.3390/pharmaceutics14091860] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Solanki R, Jodha B, Prabina KE, Aggarwal N, Patel S. Recent advances in phytochemical based nano-drug delivery systems to combat breast cancer: A review. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103832] [Reference Citation Analysis]
15 Shafiq A, Madni A, Khan S, Sultana H, Sumaira, Shah H, Khan S, Rehman S, Nawaz M. Core-shell Pluronic F127/chitosan based nanoparticles for effective delivery of methotrexate in the management of rheumatoid arthritis. Int J Biol Macromol 2022;213:465-77. [PMID: 35661673 DOI: 10.1016/j.ijbiomac.2022.05.192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Lee SH, Song JG, Han H. Site-selective oral delivery of therapeutic antibodies to the inflamed colon via a folic acid-grafted organic/inorganic hybrid nanocomposite system. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.06.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Davarnejad R, Layeghy K, Soleymani M, Ayazi A. Encapsulation of Quercetin in a Mixed Nanomicellar System to Enhance its Cytotoxicity against Breast Cancer Cells. Chem Eng & Technol 2022;45:1100-5. [DOI: 10.1002/ceat.202200025] [Reference Citation Analysis]
18 Afroze N, Pramodh S, Shafarin J, Bajbouj K, Hamad M, Sundaram MK, Haque S, Hussain A. Fisetin Deters Cell Proliferation, Induces Apoptosis, Alleviates Oxidative Stress and Inflammation in Human Cancer Cells, HeLa. Int J Mol Sci 2022;23:1707. [PMID: 35163629 DOI: 10.3390/ijms23031707] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Elsallabi O, Patruno A, Pesce M, Cataldi A, Carradori S, Gallorini M. Fisetin as a Senotherapeutic Agent: Biopharmaceutical Properties and Crosstalk between Cell Senescence and Neuroprotection. Molecules 2022;27:738. [PMID: 35164003 DOI: 10.3390/molecules27030738] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
20 Nguyen NT, Bui QA, Nguyen HHN, Nguyen TT, Ly KL, Tran HLB, Doan VN, Nhi TTY, Nguyen NH, Nguyen NH, Tran NQ, Nguyen DT. Curcuminoid Co-Loading Platinum Heparin-Poloxamer P403 Nanogel Increasing Effectiveness in Antitumor Activity. Gels 2022;8:59. [DOI: 10.3390/gels8010059] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
21 Yang Y, Alencar LMR, Pijeira MSO, Batista BDS, França ARS, Rates ERD, Lima RC, Gemini-piperni S, Santos-oliveira R. [ 223 Ra] RaCl 2 nanomicelles showed potent effect against osteosarcoma: targeted alpha therapy in the nanotechnology era. Drug Delivery 2022;29:186-91. [DOI: 10.1080/10717544.2021.2005719] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
22 Singla P, Garg S, McClements J, Jamieson O, Peeters M, Mahajan RK. Advances in the therapeutic delivery and applications of functionalized Pluronics: A critical review. Adv Colloid Interface Sci 2022;299:102563. [PMID: 34826745 DOI: 10.1016/j.cis.2021.102563] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
23 Marques SM, Kumar L. Mechanism of polymeric micelles for drug targeting to brain tumors. Nanocarriers for Drug-Targeting Brain Tumors 2022. [DOI: 10.1016/b978-0-323-90773-6.00022-1] [Reference Citation Analysis]
24 Ebrahimnejad P, Sodagar Taleghani A, Asare-Addo K, Nokhodchi A. An updated review of folate-functionalized nanocarriers: A promising ligand in cancer. Drug Discov Today 2021:S1359-6446(21)00490-6. [PMID: 34781032 DOI: 10.1016/j.drudis.2021.11.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
25 Ibharm SF, Ismail NI, Jusoh N. Preparation and Evaluation of Folic Acid-TPGS Polymeric Micelle as a Quercetin Anticancer Drug Carrier. 2021 IEEE International Biomedical Instrumentation and Technology Conference (IBITeC) 2021. [DOI: 10.1109/ibitec53045.2021.9649094] [Reference Citation Analysis]
26 Uttekar PS, Yadav VD, Bhagwat DA. 1, 2-Dihexadecanoyl-sn-glycero-3-phosphoethanolamin (DPPE), doxorubicin and folic acid conjugated micelles for cancer management in tumor bearing BALB/c mice. Bioorg Med Chem Lett 2021;50:128337. [PMID: 34438013 DOI: 10.1016/j.bmcl.2021.128337] [Reference Citation Analysis]
27 Kandekar U, Pujari R. Nanocarrier based precise approaches for anticancer agents in treatment of breast cancer. Hacettepe University Journal of the Faculty of Pharmacy 2021. [DOI: 10.52794/hujpharm.891355] [Reference Citation Analysis]
28 Liu WY, Lin CC, Hsieh YS, Wu YT. Nanoformulation Development to Improve the Biopharmaceutical Properties of Fisetin Using Design of Experiment Approach. Molecules 2021;26:3031. [PMID: 34069585 DOI: 10.3390/molecules26103031] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
29 Soleymani M, Velashjerdi M, Asgari M. Preparation of hyaluronic acid-decorated mixed nanomicelles for targeted delivery of hydrophobic drugs to CD44-overexpressing cancer cells. Int J Pharm 2021;592:120052. [PMID: 33159986 DOI: 10.1016/j.ijpharm.2020.120052] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
30 Shetty V, Jakhade A, Shinde K, Chikate R, Kaul-ghanekar R. Folate mediated targeted delivery of cinnamaldehyde loaded and FITC functionalized magnetic nanoparticles in breast cancer: in vitro , in vivo and pharmacokinetic studies. New J Chem 2021;45:1500-15. [DOI: 10.1039/d0nj04319b] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Imran M, Saeed F, Gilani SA, Shariati MA, Imran A, Afzaal M, Atif M, Tufail T, Anjum FM. Fisetin: An anticancer perspective. Food Sci Nutr 2021;9:3-16. [PMID: 33473265 DOI: 10.1002/fsn3.1872] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 10.7] [Reference Citation Analysis]
32 Van Thoai D, Nguyen DT, Dang LH, Nguyen NH, Nguyen VT, Doan P, Nguyen BT, Le Van Thu, Tung NN, Quyen TN. Lipophilic effect of various pluronic-grafted gelatin copolymers on the quercetin delivery efficiency in these self-assembly nanogels. J Polym Res 2020;27. [DOI: 10.1007/s10965-020-02216-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
33 Jarak I, Varela CL, Tavares da Silva E, Roleira FF, Veiga F, Figueiras A. Pluronic-based nanovehicles: Recent advances in anticancer therapeutic applications. European Journal of Medicinal Chemistry 2020;206:112526. [DOI: 10.1016/j.ejmech.2020.112526] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
34 Chen LF, Xu PY, Fu CP, Kankala RK, Chen AZ, Wang SB. Fabrication of Supercritical Antisolvent (SAS) Process-Assisted Fisetin-Encapsulated Poly (Vinyl Pyrrolidone) (PVP) Nanocomposites for Improved Anticancer Therapy. Nanomaterials (Basel) 2020;10:E322. [PMID: 32070047 DOI: 10.3390/nano10020322] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
35 El-hady SM, Aboughaly MH, El-ashmoony MM, Helmy HS, El-gazayerly ON. Colon targeting of celecoxib nanomixed micelles using pulsatile drug delivery systems for the prevention of inflammatory bowel disease. International Journal of Pharmaceutics 2020;576:118982. [DOI: 10.1016/j.ijpharm.2019.118982] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
36 Alqaraghuli HGJ, Kashanian S, Rafipour R. A Review on Targeting Nanoparticles for Breast Cancer. Curr Pharm Biotechnol 2019;20:1087-107. [PMID: 31364513 DOI: 10.2174/1389201020666190731130001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
37 Gürler SB, Kiraz Y, Baran Y. Flavonoids in cancer therapy: current and future trends. Biodiversity and Biomedicine 2020. [DOI: 10.1016/b978-0-12-819541-3.00021-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
38 El-readi MZ, Althubiti MA. Cancer Nanomedicine: A New Era of Successful Targeted Therapy. Journal of Nanomaterials 2019;2019:1-13. [DOI: 10.1155/2019/4927312] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 9.3] [Reference Citation Analysis]
39 Rajpoot K, Jain SK. Irinotecan hydrochloride trihydrate loaded folic acid-tailored solid lipid nanoparticles for targeting colorectal cancer: development, characterization, and in vitro cytotoxicity study using HT-29 cells. J Microencapsul 2019;36:659-76. [PMID: 31495238 DOI: 10.1080/02652048.2019.1665723] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
40 Baidya D, Kushwaha J, Mahadik K, Patil S. Chrysin-loaded folate conjugated PF127-F68 mixed micelles with enhanced oral bioavailability and anticancer activity against human breast cancer cells. Drug Development and Industrial Pharmacy 2019;45:852-60. [DOI: 10.1080/03639045.2019.1576726] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
41 Mehta P, Pawar A, Mahadik K, Bothiraja C. Emerging novel drug delivery strategies for bioactive flavonol fisetin in biomedicine. Biomedicine & Pharmacotherapy 2018;106:1282-91. [DOI: 10.1016/j.biopha.2018.07.079] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 5.6] [Reference Citation Analysis]
42 Varghese E, Samuel SM, Abotaleb M, Cheema S, Mamtani R, Büsselberg D. The "Yin and Yang" of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers. Cancers (Basel) 2018;10:E346. [PMID: 30248941 DOI: 10.3390/cancers10100346] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 11.0] [Reference Citation Analysis]
43 Ding P, Shen H, Wang J, Ju J. Improved oral bioavailability of magnolol by using a binary mixed micelle system. Artif Cells Nanomed Biotechnol 2018;46:668-74. [PMID: 30183380 DOI: 10.1080/21691401.2018.1468339] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
44 Poudel I, Ahiwale R, Pawar A, Mahadik K, Bothiraja C. Development of novel biotinylated chitosan-decorated docetaxel-loaded nanocochleates for breast cancer targeting. Artif Cells Nanomed Biotechnol 2018;46:229-40. [PMID: 29575931 DOI: 10.1080/21691401.2018.1453831] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
45 Bothiraja C, Rajput N, Poudel I, Rajalakshmi S, Panda B, Pawar A. Development of novel biofunctionalized chitosan decorated nanocochleates as a cancer targeted drug delivery platform. Artificial Cells, Nanomedicine, and Biotechnology 2018;46:447-61. [DOI: 10.1080/21691401.2018.1430584] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]